A Review of Transcranial Magnetic Stimulation in Vascular Dementia

Vascular dementia (VaD) is a clinical syndrome that encompasses a wide spectrum of cognitive disorders caused by cerebrovascular disease. The subcortical ischemic form of VaD is clinically homogeneous and a major cause of cognitive impairment in the elderly. Vascular lesions contribute to cognitive decline in neurodegenerative dementias, and VaD and Alzheimer’s disease often coexist and share clinical features and multiple neurotransmission involvement. These similarities have led several investigators to use transcranial magnetic stimulation (TMS) to enucleate a neurophysiological profile of VaD. TMS studies have identified a pattern of cortical hyperexcitability probably related to the disruption of the integrity of white matter lesions due to cerebrovascular disease. The present review provides a perspective of these TMS techniques by further understanding the role of different neurotransmission pathways and plastic remodeling of neuronal networks in the pathogenesis of VaD.

[1]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[2]  Frederik Barkhof,et al.  Longitudinal Cognitive Decline in Subcortical Ischemic Vascular Disease – The LADIS Study , 2009, Cerebrovascular Diseases.

[3]  W. M. van der Flier,et al.  Diffusion-Weighted Imaging and Cognition in the Leukoariosis and Disability in the Elderly Study , 2010, Stroke.

[4]  P J Delwaide,et al.  Ipsilateral Motor Responses to Focal Transcranial Magnetic Stimulation in Healthy Subjects and Acute-Stroke Patients , 2001, Stroke.

[5]  T. Erkinjuntti,et al.  Diagnosis and management of vascular cognitive impairment and dementia. , 2002, Journal of neural transmission. Supplementum.

[6]  M. Tymianski,et al.  Calcium, ischemia and excitotoxicity. , 2010, Cell calcium.

[7]  R. Robinson,et al.  Treatment of vascular depression using repetitive transcranial magnetic stimulation. , 2008, Archives of general psychiatry.

[8]  Yan Cheng,et al.  The Restoration After Repetitive Transcranial Magnetic Stimulation Treatment on Cognitive Ability of Vascular Dementia Rats and Its Impacts on Synaptic Plasticity in Hippocampal CA1 Area , 2010, Journal of Molecular Neuroscience.

[9]  B. Steinhoff,et al.  Effects of antiepileptic drugs on motor cortex excitability in humans: A transcranial magnetic stimulation study , 1996, Annals of neurology.

[10]  K. Rockwood,et al.  Vascular cognitive impairment: current concepts and clinical developments , 2008, The Lancet Neurology.

[11]  D. Choi,et al.  Ischemia-induced neuronal apoptosis , 1996, Current Opinion in Neurobiology.

[12]  B. Reed,et al.  Affective behavioural disturbances in Alzheimer's disease and ischaemic vascular disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[13]  Antonio Daniele,et al.  Functional evaluation of cerebral cortex in dementia with Lewy bodies , 2007, NeuroImage.

[14]  R. Kalaria Comparison between Alzheimer's disease and vascular dementia: Implications for treatment , 2003, Neurological research.

[15]  G Gainotti,et al.  Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  Paolo Maria Rossini,et al.  Motor cortex excitability in Alzheimer's disease: A transcranial magnetic stimulation study , 2003, Annals of neurology.

[17]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[18]  E. Esposito,et al.  Serotonin-dopamine interaction: electrophysiological evidence. , 2008, Progress in brain research.

[19]  Manuela Pennisi,et al.  Motor cortex hyperexcitability in subcortical ischemic vascular dementia. , 2011, Archives of gerontology and geriatrics.

[20]  K. Nakashima,et al.  Short latency afferent inhibition is not impaired in mild cognitive impairment , 2007, Clinical Neurophysiology.

[21]  V. Di Lazzaro,et al.  Use of transcranial magnetic stimulation of the brain in stroke rehabilitation , 2007, Expert review of neurotherapeutics.

[22]  P. Pasqualetti,et al.  Motor cortex plasticity predicts recovery in acute stroke. , 2010, Cerebral cortex.

[23]  M S Mega,et al.  Frontal-subcortical circuits and neuropsychiatric disorders. , 1994, The Journal of neuropsychiatry and clinical neurosciences.

[24]  M. Mesulam,et al.  Cholinergic denervation in a pure multi-infarct state , 2003, Neurology.

[25]  Raffaele Ferri,et al.  Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity , 2001, Neuroscience Letters.

[26]  Sandra E Black,et al.  Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter? , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[27]  Robert D. Harris,et al.  Vascular , 1993 .

[28]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[29]  鯨井 隆 Corticocortical inhibition in human motor cortex , 1994 .

[30]  A Brun,et al.  CORRELATIONS BETWEEN HISTOPATHOLOGIC WHITE MATTER CHANGES AND PROTON MR RELAXATION TIMES IN DEMENTIA , 1987, Alzheimer disease and associated disorders.

[31]  Executive control function: a rational basis for the diagnosis of vascular dementia. , 1999, Alzheimer disease and associated disorders.

[32]  C. Lyketsos,et al.  Vascular dementia and Alzheimer's disease: is there a difference? A comparison of symptoms by disease duration. , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[33]  Á. Esteban,et al.  Cortical excitability in very mild Alzheimer’s disease: a long-term follow-up study , 2010, Journal of Neurology.

[34]  G. Román,et al.  Vascular dementia may be the most common form of dementia in the elderly , 2002, Journal of the Neurological Sciences.

[35]  E Costanzo,et al.  Transcranial magnetic stimulation after pure motor stroke , 2002, Clinical Neurophysiology.

[36]  J. Rothwell,et al.  Short latency inhibition of human hand motor cortex by somatosensory input from the hand , 2000, The Journal of physiology.

[37]  Doo Yeon Kim,et al.  Cellular and molecular pathways of ischemic neuronal death. , 2002, Journal of biochemistry and molecular biology.

[38]  G. C. Román,et al.  Vascular dementia , 1993, Neurology.

[39]  Timo Erkinjuntti,et al.  The concept of vascular cognitive impairment. , 2009, Frontiers of neurology and neuroscience.

[40]  P. Ashby,et al.  Mechanism of the silent period following transcranial magnetic stimulation Evidence from epidural recordings , 1999, Experimental Brain Research.

[41]  M. G. Marciani,et al.  Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia , 2004, Clinical Neurophysiology.

[42]  M. Mesulam,et al.  Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. , 1998, Brain : a journal of neurology.

[43]  G. Bernardi,et al.  l-dopa modulates motor cortex excitability in Alzheimer’s disease patients , 2008, Journal of Neural Transmission.

[44]  P. Delwaide,et al.  Can motor recovery in stroke patients be predicted by early transcranial magnetic stimulation? , 1996, Stroke.

[45]  P M Rossini,et al.  Mapping of motor cortical reorganization after stroke. A brain stimulation study with focal magnetic pulses. , 1997, Stroke.

[46]  B. Reisberg,et al.  Vascular cognitive impairment , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[47]  J. Lou,et al.  Cortical excitability and age-related volumetric MRI changes , 2006, Clinical Neurophysiology.

[48]  Pedro C. Miranda,et al.  Magnetic stimulation in Alzheimer’s disease , 1997, Journal of Neurology.

[49]  A. Hofman,et al.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[50]  R. Kalaria Similarities between Alzheimer's disease and vascular dementia , 2002, Journal of the Neurological Sciences.

[51]  J. Rothwell,et al.  Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex , 2000, Clinical Neurophysiology.

[52]  J. Liepert,et al.  Motor cortex disinhibition in Alzheimer's disease , 2001, Clinical Neurophysiology.

[53]  H. Siebner,et al.  Age-related decrease in paired-pulse intracortical inhibition in the human primary motor cortex , 2001, Neuroscience Letters.

[54]  A. Hofman,et al.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[55]  M. Minami,et al.  Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats , 1994, Neuroscience Letters.

[56]  J. Cummings Frontal-subcortical circuits and human behavior. , 1998, Archives of neurology.

[57]  E. Perry,et al.  Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types , 2000, Acta neurologica Scandinavica. Supplementum.

[58]  P. M. Rossini,et al.  Age-related changes of motor evoked potentials in healthy humans: Non-invasive evaluation of central and peripheral motor tracts excitability and conductivity , 1992, Brain Research.

[59]  Thomas G. Beach,et al.  Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[60]  P. Scheltens,et al.  Impact of Age-Related Cerebral White Matter Changes on the Transition to Disability – The LADIS Study: Rationale, Design and Methodology , 2004, Neuroepidemiology.

[61]  L. Santoro,et al.  Motor cortex cholinergic dysfunction in CADASIL: A transcranial magnetic demonstration , 2008, Clinical Neurophysiology.

[62]  R. Ferri,et al.  Motor cortex excitability in Alzheimer's disease and in subcortical ischemic vascular dementia , 2004, Neuroscience Letters.

[63]  S. Rossi,et al.  Clinical neurophysiology of aging brain: From normal aging to neurodegeneration , 2007, Progress in Neurobiology.

[64]  S. Ghirlanda,et al.  Neurophysiological predictors of long term response to AChE inhibitors in AD patients , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[65]  H Shibasaki,et al.  Decrease in Cortical Benzodiazepine Receptors in Symptomatic Patients With Leukoaraiosis: A Positron Emission Tomography Study , 2004, Stroke.

[66]  S. Paolucci,et al.  Clinical Presentation and Outcome of Geriatric Depression in Subcortical Ischemic Vascular Disease , 2009, Gerontology.

[67]  P. Delwaide,et al.  Motor cortex inhibition is not impaired in patients with Alzheimer’s disease: evidence from paired transcranial magnetic stimulation , 1999, Journal of the Neurological Sciences.

[68]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[69]  B. Platt,et al.  Glutamate receptor function in learning and memory , 2003, Behavioural Brain Research.

[70]  C. Schönfeldt-Lecuona,et al.  The value of neuronavigated rTMS for the treatment of depression , 2010, Neurophysiologie Clinique/Clinical Neurophysiology.

[71]  H. Chui,et al.  Subcortical ischaemic vascular dementia , 2002, The Lancet Neurology.

[72]  M J Firbank,et al.  Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study , 2009, Psychological Medicine.

[73]  Robert H. Perry,et al.  Neurotransmitter enzyme abnormalities in senile dementia Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue , 1977, Journal of the Neurological Sciences.

[74]  P. A. Tonali,et al.  Effects of aging on motor cortex excitability , 2006, Neuroscience Research.

[75]  J C Rothwell,et al.  Origin of facilitation of motor-evoked potentials after paired magnetic stimulation: direct recording of epidural activity in conscious humans. , 2006, Journal of neurophysiology.

[76]  Petro Julkunen,et al.  Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: A pilot study , 2008, Journal of Neuroscience Methods.

[77]  K. Fuxe,et al.  Reciprocal dopamine-glutamate modulation of release in the basal ganglia. , 1998, Neurochemistry international.

[78]  S. Golaszewski,et al.  Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study , 2008, Journal of Neural Transmission.

[79]  I. Rektor,et al.  Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients , 2005, Journal of the Neurological Sciences.

[80]  F. Salvi,et al.  An italian kindred with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) , 1995, Annals of neurology.

[81]  C. Montigny,et al.  Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial , 2004, International journal of geriatric psychiatry.

[82]  R. Bella,et al.  Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations , 2005, Neuroscience Letters.

[83]  J. Bowler The concept of vascular cognitive impairment , 2002, Journal of the Neurological Sciences.

[84]  Victor De Pasqua,et al.  Post-stroke reorganization of hand motor area: a 1-year prospective follow-up with focal transcranial magnetic stimulation , 2003, Clinical Neurophysiology.

[85]  Raffaele Ferri,et al.  Motor cortex excitability in Alzheimer disease: one year follow-up study , 2002, Neuroscience Letters.

[86]  J. Rothwell,et al.  Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex , 2000, Experimental Brain Research.

[87]  R. Kalaria,et al.  Cholinergic Neuronal Deficits in CADASIL , 2007, Stroke.

[88]  Mark Hallett,et al.  Mechanisms of Deafferentation-Induced Plasticity in Human Motor Cortex , 1998, The Journal of Neuroscience.

[89]  J. Tepper,et al.  GABAergic control of substantia nigra dopaminergic neurons. , 2007, Progress in brain research.

[90]  P. Rossini,et al.  Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. , 1994, Electroencephalography and clinical neurophysiology.

[91]  J. Rothwell,et al.  Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation , 2002, Neurology.

[92]  R. Kalaria Arteriosclerosis, apolipoprotein E, and Alzheimer's disease , 1997, The Lancet.

[93]  Volker Hömberg,et al.  Remote changes in cortical excitability after stroke. , 2003, Brain : a journal of neurology.

[94]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[95]  V. Hachinski Vascular dementia: a radical redefinition. , 1994, Dementia.

[96]  M W Weiner,et al.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease , 2000, Neurology.

[97]  H Jick,et al.  Statins and the risk of dementia , 2000, The Lancet.

[98]  P. Scheltens,et al.  Association of gait and balance disorders with age-related white matter changes , 2008, Neurology.

[99]  J. Rothwell,et al.  The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse , 2004, Clinical Neurophysiology.

[100]  R. Kalaria,et al.  Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia , 2006, Neurobiology of Aging.

[101]  K. Blennow,et al.  The neurochemistry of vascular dementia. , 1994, Dementia.

[102]  H S Markus,et al.  MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL , 2001, Neurology.

[103]  P. Scheltens,et al.  Urinary Complaints in Nondisabled Elderly People with Age‐Related White Matter Changes: The Leukoaraiosis And DISability (LADIS) Study , 2008, Journal of the American Geriatrics Society.

[104]  K. Fuxe,et al.  Review Article Reciprocaldopamine-glutamatemodulation of release in the basalganglia , 1998, Neurochemistry International.

[105]  R N Kalaria,et al.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. , 1996, The American journal of pathology.

[106]  Frederik Barkhof,et al.  Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort , 2009, BMJ : British Medical Journal.

[107]  C. Marra,et al.  In vivo functional evaluation of central cholinergic circuits in vascular dementia , 2008, Clinical Neurophysiology.

[108]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[109]  A. Oliviero,et al.  In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias , 2006, Neurology.

[110]  P. Pasqualetti,et al.  Interhemispheric Asymmetries of Motor Cortex Excitability in the Postacute Stroke Stage: A Paired-Pulse Transcranial Magnetic Stimulation Study , 2003, Stroke.

[111]  M Hallett,et al.  Dextromethorphan decreases the excitability of the human motor cortex , 1998, Neurology.

[112]  P. Matthews,et al.  Functional Reorganization of Motor Cortex Increases With Greater Axonal Injury From CADASIL , 2002, Stroke.

[113]  P. Mcgeer,et al.  Neurotransmitters and their receptors in the basal ganglia. , 1993, Advances in neurology.

[114]  H. Saito,et al.  Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats. , 2000, Toxicology.

[115]  A. Oliviero,et al.  Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans , 2005, The Journal of physiology.

[116]  A. Berardelli,et al.  Altered response to rTMS in patients with Alzheimer's disease , 2006, Clinical Neurophysiology.